This study is looking at a new administration method for an approved drug, which is currently being used to treat severe osteoporosis in patients who are at high risk for fracture or for patients who are intolerant to other osteoporosis therapies.
Osteoporosis is a condition that causes the bones to be weak and brittle. The purpose of this study is to study this drug when it is administered using a capsule. This is a new device that delivers medications orally rather than via injections.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
People in this group, may be required to attend additional appointments.
Call us on 1800 243 733 to discuss your eligibility today!